Growth Metrics

Q32 Bio (QTTB) Shares Outstanding (Diluted Average) (2021 - 2026)

Q32 Bio's quarterly Shares Outstanding (Diluted Average) came in at $14.1 million in Q1 2026, up 15.56% year-on-year from $12.2 million in Q1 2025, and up 14.46% quarter-over-quarter from $12.3 million in Q4 2025.

Q32 Bio has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $14.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 15.56% year-over-year to $14.1 million; the trailing twelve-month figure through Mar 2026 stood at $14.1 million (up 15.56% YoY), and the FY2025 full-year result was $12.3 million, up 27.51% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $14.1 million, up from $12.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $57.9 million in Q1 2022, with the low at $344623.0 in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $19.3 million, with a median of $12.2 million recorded in 2025.
  • Year-over-year, Shares Outstanding (Diluted Average) sank 99.4% in 2023 and surged 3338.63% in 2024.
  • Tracing QTTB's Shares Outstanding (Diluted Average) over 5 years: stood at $57.4 million in 2022, then slumped by 99.39% to $349060.0 in 2023, then soared by 2666.77% to $9.7 million in 2024, then rose by 27.51% to $12.3 million in 2025, then increased by 14.46% to $14.1 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $14.1 million (Q1 2026), $12.3 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Q32 Bio 162.94 Mn 112.19 Mn - 14.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.10 Mn
Dec 31, 2025 12.31 Mn
Sep 30, 2025 12.21 Mn
Jun 30, 2025 12.20 Mn
Mar 31, 2025 12.20 Mn
Dec 31, 2024 9.66 Mn
Sep 30, 2024 8.81 Mn
Jun 30, 2024 11.96 Mn
Mar 31, 2024 2.33 Mn
Dec 31, 2023 349,060.00
Sep 30, 2023 346,288.00
Jun 30, 2023 347,936.00
Mar 31, 2023 344,623.00
Dec 31, 2022 57.40 Mn
Sep 30, 2022 57.45 Mn
Jun 30, 2022 57.39 Mn
Mar 31, 2022 57.88 Mn
Dec 31, 2021 55.28 Mn
Sep 30, 2021 57.11 Mn
Jun 30, 2021 53.43 Mn
Mar 31, 2021 50.36 Mn